Physician profile
Megan Couso
NPI 1265922546
$7,314.98
in general payments reported to CMS, 2019-2025
12 companies · $422 in 2025
The $422 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,968 · 2021: $502 · 2022: $153 · 2023: $2,291 · 2024: $1,979 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,122 · Grant: $1,350 · Travel and Lodging: $1,137 · Education: $82.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,121.74 |
| Grant | $1,350.00 |
| Travel and Lodging | $1,136.55 |
| Education | $82.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,534.95 | 2019-2024 | |
| Depuy Synthes Sales INC. | $1,298.24 | 2021-2025 | Na, Hammerlock, Motoband |
| Smith+Nephew, INC. | $1,262.44 | 2023 | Evos, Trigen, Real Intelligence |
| Stryker Corporation | $550.66 | 2023-2025 | Pro, Pelvis II, T2 |
| Zimmer Biomet Holdings, INC. | $238.84 | 2021-2025 | Persona |
| Vericel Corporation | $123.52 | 2022 | |
| Integra Lifesciences Corporation | $103.97 | 2019-2021 | |
| Convatec INC. | $52.09 | 2019 | |
| Orthalign INC | $51.75 | 2025 | Orthalign Plus |
| Globus Medical, INC. | $34.26 | 2023 | Tibial Nail |
| Skeletal Dynamics INC | $32.86 | 2019 | |
| Medtronic, INC. | $31.40 | 2021-2025 | Mazor X System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Couso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.